Clinical management update: evaluation and management of older patients with breast cancer

Journal of the American Geriatrics Society
Cynthia Owusu

Abstract

Recent gains in life expectancy, coupled with aging as a risk factor for breast cancer, make breast cancer primarily a disease of older women. Evaluation of the biology of breast cancer according to age has suggested that estrogen receptor-positive, low-S-phase, low-tumor-grade, and human epidermal growth factor receptor 2-negative tumors are more common in older than younger women. However, this has not translated into any major survival advantage for older women with breast cancer over their younger counterparts. Several reasons, including undertreatment and underrepresentation in clinical trials, may account for this age-related disparity. In this brief review, recent practice-changing breast cancer updates of relevance to the care of older patients with breast cancer are discussed and summarized. Because the population is aging and the number of older patients with breast cancer will continue to increase, it is imperative that older patients with breast cancer be encouraged to participate in cutting edge research and that state-of-the-art oncology care be provided to this underserved population.

References

Dec 9, 1997·Journal of the National Cancer Institute·B FisherR G Margolese
Mar 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joy H LewisJosé J Escarce
Apr 2, 2003·Urology·Douglas ScherrUNKNOWN National Comprehensive Cancer Network
Sep 3, 2004·The New England Journal of Medicine·Kevin S HughesUNKNOWN Eastern Cooperative Oncology Group
Sep 8, 2004·Lancet·Bernard FisherUNKNOWN National Surgical Adjuvant Breast and Bowel Project randomised clinical trials
Dec 14, 2004·The New England Journal of Medicine·Soonmyung PaikNorman Wolmark
Oct 21, 2005·The New England Journal of Medicine·Edward H RomondNorman Wolmark
May 25, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Soonmyung PaikNorman Wolmark
Dec 12, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cynthia OwusuRebecca A Silliman
Jan 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ann H PartridgeAviva Asnis-Alibozek
Feb 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joseph A Sparano, Soonmyung Paik

❮ Previous
Next ❯

Citations

Jan 30, 2014·Journal of Geriatric Oncology·Heather S Laird-FickNikolay V Dimitrov
Jul 11, 2012·ANZ Journal of Surgery·David M RoderIan D Campbell
Mar 24, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Laura C Hanson, Hyman B Muss

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Sharon H GiordanoMelissa L Bondy
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Benjamin D SmithThomas A Buchholz
© 2021 Meta ULC. All rights reserved